Glucose-induced Changes in Na+/H+ Antiport Activity and Gene Expression in Cultured Vascular Smooth Muscle Cells. Role of Protein Kinase C
Overview
Authors
Affiliations
Increased Na+/H+ antiport activity has been implicated in the pathogenesis of hypertension and vascular disease in diabetes mellitus. The independent effect of elevated extracellular glucose concentrations on Na+/H+ antiport activity in cultured rat vascular smooth muscle cells (VSMC) was thus examined. Amiloride-sensitive 22Na+ uptake by VSMC significantly increased twofold after 3 and 24 h of exposure to high glucose medium (20 mM) vs. control medium (5 mM). Direct glucose-induced Na+/H+ antiport activation was confirmed by measuring Na(+)-dependent intracellular pH recovery from intracellular acidosis. High glucose significantly increased protein kinase C (PKC) activity in VSMC and inhibition of PKC activation with H-7, staurosporine, or prior PKC downregulation prevented glucose-induced increases in Na+/H+ antiport activity in VSMC. Northern analysis of VSMC poly A+ RNA revealed that high glucose induced a threefold increase in Na+/H+ antiport (NHE-1) mRNA at 24 h. Inhibiting this increase in NHE-1 mRNA with actinomycin D prevented the sustained glucose-induced increase in Na+/H+ antiport activity. In conclusion, elevated glucose concentrations significantly influence vascular Na+/H+ antiport activity via glucose-induced PKC dependent mechanisms, thereby providing a biochemical basis for increased Na+/H+ antiport activity in the vascular tissues of patients with hypertension and diabetes mellitus.
Inhibition of c-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide via NHE1 Upregulation.
Cao S, Xiong Q, Ding B, Wang X, Wei F, Sun Q Oxid Med Cell Longev. 2022; 2022:9306614.
PMID: 35915613 PMC: 9338868. DOI: 10.1155/2022/9306614.
Dysregulated Erythroid Mg Efflux in Type 2 Diabetes.
Ferreira A, Rivera A, Wohlgemuth J, Dlott J, Snyder L, Alper S Front Cell Dev Biol. 2022; 10:861644.
PMID: 35445032 PMC: 9013827. DOI: 10.3389/fcell.2022.861644.
Harguindey S, Alfarouk K, Polo Orozco J, Fais S, Devesa J Int J Mol Sci. 2020; 21(20).
PMID: 33050492 PMC: 7589677. DOI: 10.3390/ijms21207475.
Birkeland E, Koch L, Dechant R Front Oncol. 2020; 10:1561.
PMID: 32974190 PMC: 7462004. DOI: 10.3389/fonc.2020.01561.
Harguindey S, Alfarouk K, Polo Orozco J, Hardonniere K, Stanciu D, Fais S Int J Mol Sci. 2020; 21(3).
PMID: 32046158 PMC: 7036897. DOI: 10.3390/ijms21031110.